Algert Global’s Acceleron Pharma XLRN Stock Holding History

Algert Global’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-5,358	Closed	-$922K	–	1177
2021 Q3	$922K	Buy	+5,358	New	+$701K	0.12%	268
2020 Q2	–	Sell	-5,281	Closed	-$475K	–	530
2020 Q1	$475K	Buy	+5,281	New	+$410K	0.2%	171

Algert Global's XLRN Position: Q4 2021 in Review

Algert Global sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 5,358 shares — an estimated $922K sold.

Algert Global first reported a position in XLRN in Q1 2020 and held it in 2 quarters. The position peaked at $922K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

Algert Global reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
Algert Global sold 5,358 Acceleron Pharma shares in Q4 2021, an estimated $922K.
Algert Global first reported a position in Acceleron Pharma in Q1 2020 and held it in 2 quarters.
Algert Global's Acceleron Pharma position peaked at $922K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on Algert Global's 13F filing for Q4 2021, filed 14 Feb 2022.